Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
The Effect of the Selective N-methyl-D-aspartate (NMDA) Receptor GluN2B Subunit Antagonist CP-101,606 on Cytochrome P450 2D (CYP2D) Expression and Activity in the Rat Liver and Brain.
Int J Mol Sci. 2022 Nov 8;23(22):13746. doi: 10.3390/ijms232213746.
Int J Mol Sci. 2022.
PMID: 36430225
Free PMC article.
The impact of noradrenergic neurotoxin DSP-4 and noradrenaline transporter knockout (NET-KO) on the activity of liver cytochrome P450 3A (CYP3A) in male and female mice.
Bromek E, Danek PJ, Wójcikowski J, Basińska-Ziobroń A, Pukło R, Solich J, Dziedzicka-Wasylewska M, Daniel WA.
Bromek E, et al. Among authors: danek pj.
Pharmacol Rep. 2022 Oct;74(5):1107-1114. doi: 10.1007/s43440-022-00406-8. Epub 2022 Aug 26.
Pharmacol Rep. 2022.
PMID: 36018449
Free PMC article.
Item in Clipboard
The Selective NMDA Receptor GluN2B Subunit Antagonist CP-101,606 with Antidepressant Properties Modulates Cytochrome P450 Expression in the Liver.
Bromek E, Haduch A, Rysz M, Jastrzębska J, Pukło R, Wójcikowska O, Danek PJ, Daniel WA.
Bromek E, et al. Among authors: danek pj.
Pharmaceutics. 2021 Oct 9;13(10):1643. doi: 10.3390/pharmaceutics13101643.
Pharmaceutics. 2021.
PMID: 34683936
Free PMC article.
Item in Clipboard
Cite
Cite